Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Patrono

Showing results (201-210 of 227) with videos related to

Pageof 23
Sort By:
The Journal of Clinical Investigation|September 1, 1985
Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosusC Patrono, G Ciabattoni, G Remuzzi, et al.
The Journal of Clinical Investigation|January 1, 1982
Evidence for a direct stimulatory effect of prostacyclin on renin release in manC Patrono, F Pugliese, G Ciabattoni, et al.
British Journal of Pharmacology|July 1, 1996
Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formationP Patrignani, G Santini, M R Panara, et al.
British Journal of Pharmacology|November 1, 1995
Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthasesM R Panara, A Greco, G Santini, et al.
Circulation|September 6, 2001
Oxidative stress and platelet activation in homozygous homocystinuriaG Davì, G Di Minno, A Coppola, et al.
Circulation|January 20, 1999
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementationG Davì, G Ciabattoni, A Consoli, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjectsM R Panara, G Renda, M G Sciulli, et al.
Circulation|August 19, 1997
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable anginaF Cipollone, P Patrignani, A Greco, et al.
The Journal of Clinical Investigation|March 1, 1983
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defectG Remuzzi, A Benigni, P Dodesini, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1983
Evidence for a renal origin of urinary thromboxane B2 in health and diseaseC Patrono, G Ciabattoni, P Patrignani, et al.
Pageof 23

Showing results (201-210 of 227) with videos related to

Sort By:
Pageof 23
The Journal of Clinical Investigation|September 1, 1985
Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosusC Patrono, G Ciabattoni, G Remuzzi, et al.
The Journal of Clinical Investigation|January 1, 1982
Evidence for a direct stimulatory effect of prostacyclin on renin release in manC Patrono, F Pugliese, G Ciabattoni, et al.
British Journal of Pharmacology|July 1, 1996
Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formationP Patrignani, G Santini, M R Panara, et al.
British Journal of Pharmacology|November 1, 1995
Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthasesM R Panara, A Greco, G Santini, et al.
Circulation|September 6, 2001
Oxidative stress and platelet activation in homozygous homocystinuriaG Davì, G Di Minno, A Coppola, et al.
Circulation|January 20, 1999
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementationG Davì, G Ciabattoni, A Consoli, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjectsM R Panara, G Renda, M G Sciulli, et al.
Circulation|August 19, 1997
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable anginaF Cipollone, P Patrignani, A Greco, et al.
The Journal of Clinical Investigation|March 1, 1983
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defectG Remuzzi, A Benigni, P Dodesini, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1983
Evidence for a renal origin of urinary thromboxane B2 in health and diseaseC Patrono, G Ciabattoni, P Patrignani, et al.
Pageof 23